Ketogenic Diet for KARS-Related Mitochondrial Dysfunction and Progressive Leukodystrophy

Abstract

KARS encodes lysyl-tRNA synthetase, which is essential for protein translation. KARS mutations sometimes cause impairment of cytoplasmic and mitochondrial protein synthesis, and sometimes lead to progressive leukodystrophies with mitochondrial signature and psychomotor regression, and follow a rapid regressive course to premature death. There has been no disease-modifying therapy beyond supportive treatment. We present a 5-year-old male patient with an asymmetrical leukodystrophy who showed overt evidence of mitochondrial dysfunction, including elevation of lactate on brain MR spectroscopy and low oxygen consumption rate in fibroblasts. We diagnosed this patient's condition as KARS-related leukodystrophy with cerebral calcification, congenital deafness, and evidence of mitochondrial dysfunction. We employed a ketogenic diet as well as multiple vitamin supplementation with the intention to alleviate mitochondrial dysfunction. The patient showed alleviation of his psychomotor regression and even partial restoration of his abilities within 4 months. This is an early report of a potential disease-modifying therapy for KARS-related progressive leukodystrophy without appreciable adverse effects.

Keywords

KARS - progressive leukodystrophy - psychomotor regression - mitochondrial dysfunction - ketogenic diet - vitamin supplementation

Publikationsverlauf

Eingereicht: 22. November 2020

Angenommen: 10. Juni 2021

Artikel online veröffentlicht:
26. August 2021

• References

• 1 Itoh M, Dai H, Horike SI. et al. Biallelic KARS pathogenic variants cause an early-onset progressive leukodystrophy. Brain 2019; 142 (03) 560-573
• 2 Sun C, Song J, Jiang Y. et al. Loss-of-function mutations in Lysyl-tRNA synthetase cause various leukoencephalopathy phenotypes. Neurol Genet 2019; 5 (02) e565
• 3 Ardissone A, Tonduti D, Legati A. et al. KARS-related diseases: progressive leukoencephalopathy with brainstem and spinal cord calcifications as new phenotype and a review of literature. Orphanet J Rare Dis 2018; 13 (01) 45
• 4 van der Knaap MS, Bugiani M, Mendes MI. et al. Biallelic variants in LARS2 and KARS cause deafness and (ovario)leukodystrophy. Neurology 2019; 92 (11) e1225-e1237
• 5 Frey S, Geffroy G, Desquiret-Dumas V. et al. The addition of ketone bodies alleviates mitochondrial dysfunction by restoring complex I assembly in a MELAS cellular model. Biochim Biophys Acta Mol Basis Dis 2017; 1863 (01) 284-291
• 6 Sullivan PG, Rippy NA, Dorenbos K, Concepcion RC, Agarwal AK, Rho JM. The ketogenic diet increases mitochondrial uncoupling protein levels and activity. Ann Neurol 2004; 55 (04) 576-580
• 7 Ahola-Erkkilä S, Carroll CJ, Peltola-Mjösund K. et al. Ketogenic diet slows down mitochondrial myopathy progression in mice. Hum Mol Genet 2010; 19 (10) 1974-1984
• 8 Steriade C, Andrade DM, Faghfoury H, Tarnopolsky MA, Tai P. Mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS) may respond to adjunctive ketogenic diet. Pediatr Neurol 2014; 50 (05) 498-502
• 9 Kang HC, Lee YM, Kim HD, Lee JS, Slama A. Safe and effective use of the ketogenic diet in children with epilepsy and mitochondrial respiratory chain complex defects. Epilepsia 2007; 48 (01) 82-88
• 10 Kang HC, Kim HD, Lee YM, Han SH. Landau-Kleffner syndrome with mitochondrial respiratory chain-complex I deficiency. Pediatr Neurol 2006; 35 (02) 158-161
• 11 Fine AS, Nemeth CL, Kaufman ML, Fatemi A. Mitochondrial aminoacyl-tRNA synthetase disorders: an emerging group of developmental disorders of myelination. J Neurodev Disord 2019; 11 (01) 29
• 12 Antonellis A, Green ED. The role of aminoacyl-tRNA synthetases in genetic diseases. Annu Rev Genomics Hum Genet 2008; 9: 87-107
• 13 Steenweg ME, Ghezzi D, Haack T. et al. Leukoencephalopathy with thalamus and brainstem involvement and high lactate ‘LTBL’ caused by EARS2 mutations. Brain 2012; 135 (Pt 5): 1387-1394
• 14 Scheidecker S, Bär S, Stoetzel C. et al. Mutations in KARS cause a severe neurological and neurosensory disease with optic neuropathy. Hum Mutat 2019; 40 (10) 1826-1840
• 15 Biancheri R, Lamantea E, Severino M. et al. Expanding the clinical and magnetic resonance spectrum of leukoencephalopathy with thalamus and brainstem involvement and high lactate (LTBL) in a patient harboring a novel EARS2 mutation. JIMD Rep 2015; 23: 85-89